Changliang Dai

Title: Changliang Dai: Innovator in Pharmaceutical Development

Introduction

Changliang Dai is a prolific inventor based in Zhejiang, China, known for his contributions to the pharmaceutical industry. With a total of three patents to his name, Dai's work primarily focuses on the development of innovative drug formulations and methods.

Latest Patents

One of Changliang Dai's latest patents is the **HS-25 tablet and preparation method therefor**. This patent outlines an HS-25 tablet created through a meticulous process involving wet granulation, drying, granulating, and tablet pressing using HS-25 and various excipients. Additionally, he has developed a patent for **ginsenoside C-K polymorphic compounds and method for preparing same**. This patent consists of several types of ginsenoside polymorphic substances, highlighting new crystal forms A, B, C, E, F, I, K, L, M, N, and O, alongside methods for their preparation.

Career Highlights

Changliang Dai is part of the team at **Zhejiang Hisun Pharmaceutical Co., Ltd.**, a company renowned for its focus on pharmaceutical innovation. His inventive mind and dedication to research have positioned him as a valuable asset in the field, contributing to advancements that potentially improve therapeutic outcomes.

Collaborations

Dai collaborates closely with colleagues such as Guobin Ren and Jinyao Chen, with whom he shares insights and knowledge that enhance their collective work at Zhejiang Hisun Pharmaceutical Co., Ltd. Their teamwork exemplifies a commitment to advancing pharmaceutical sciences and bringing novel products to market.

Conclusion

Changliang Dai stands out as an inventive force in the pharmaceutical landscape of China. His patented innovations, particularly in tablet formulations and ginsenoside compounds, illustrate his commitment to improving healthcare solutions. As he continues to collaborate with talented professionals in the field, Dai’s contributions will undoubtedly influence future advancements in pharmaceuticals.